<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707716</url>
  </required_header>
  <id_info>
    <org_study_id>32-578 ex 19/20</org_study_id>
    <nct_id>NCT04707716</nct_id>
  </id_info>
  <brief_title>Implant Supported Single Crowns With Different Retention Modes</brief_title>
  <official_title>Implant Supported Single Crowns With Different Retention Modes - Effects on Peri-implant Tissue: A Prospective Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the inflammatory response mediated by MMP-8 (Matrix&#xD;
      metalloproteinase-8 ) level in peri-implant sulcus fluid adjacent to screw-retained, cemented&#xD;
      or using the Acuris-system fixed single implant crowns as well as changing of the marginal&#xD;
      bone level within the first year after implant restoration. Furthermore periodontal&#xD;
      parameters, patient satisfaction and possible occurring biological or technical complications&#xD;
      will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After giving their written consent volunteers will be screened and eligible subjects will be&#xD;
      randomized to three different groups. In group 1 Acuris® is used as fixation type; in group 2&#xD;
      screw retention, and in group 3 cementation is used. After 3 months of submerged healing the&#xD;
      dental implants will be restored with all ceramic single implant crowns, fixed by using the&#xD;
      randomized fixation mode. Follow-up visits till one year after implant restoration will be&#xD;
      performed. At least 11 study visits during 16 months will be conducted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of marginal bone level</measure>
    <time_frame>at baseline, 4 months after implant placement and 3, 6 and 12 months after restoration</time_frame>
    <description>assessed by single tooth x-ray; in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of matrix metalloproteinase 8 level</measure>
    <time_frame>4 months after implant placement, 3, 6 and 12 months after integration of the implant crown</time_frame>
    <description>biomarker for Inflammation of peri-implant disease; in ng/ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of probing depth (PD)</measure>
    <time_frame>at baseline, 4, 7, 10, 16 months after implantation</time_frame>
    <description>using a periodontal probe; in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of occurrences of chipping</measure>
    <time_frame>measured after integration of implant crown 3, 6 and 12 months after restoration</time_frame>
    <description>visual check</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>soft tissue maintenance</measure>
    <time_frame>measured 4 months after implant placement and 3, 6 and 12 months after restoration</time_frame>
    <description>Papilla Index (Jemt T, 1997), the index ranges from 0 to 4, while 2 and 3 indicate physiological outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>technician satisfaction</measure>
    <time_frame>measured 12 months after restoration</time_frame>
    <description>evaluated using an individual questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dentist satisfaction</measure>
    <time_frame>measured 12 months after restoration</time_frame>
    <description>evaluated using an individual questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>measured at baseline, 3 and 12 months after restoration</time_frame>
    <description>evaluated using OHIP-G 14 questionnaire. The following dimensions are captured by the OHIP-G 14: functional Limitation (e.g., &quot;pronouncing any words because of problems with your teeth, mouth, dentures, or jaw?&quot;) and physical Pain (e.g., &quot;Have you had painful aching in your mouth&quot;). 14 questions are raised, which are answered using a rating scale from 0 (never) to 4 (very often).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Index (PI)</measure>
    <time_frame>at baseline, 4, 7, 10 and 16 months after implantation</time_frame>
    <description>in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on Probing (BOP)</measure>
    <time_frame>at baseline, 4, 7, 10 and 16 months after implantation</time_frame>
    <description>in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction concerning the implant crown</measure>
    <time_frame>measured 12 months after restoration</time_frame>
    <description>evaluated using an individual questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of occurrences of fractures</measure>
    <time_frame>measured after integration of implant crown 3, 6 and 12 months after restoration</time_frame>
    <description>visual check</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of occurrences of screw loosening</measure>
    <time_frame>measured after integration of implant crown 3, 6 and 12 months after restoration</time_frame>
    <description>visual check</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of occurrences of crown loosening</measure>
    <time_frame>measured after integration of implant crown 3, 6 and 12 months after restoration</time_frame>
    <description>visual check</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">39</enrollment>
  <condition>Complications: Inflammatory Reactions, Mechanical Complications</condition>
  <arm_group>
    <arm_group_label>conometric concept (Acuris system)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single implant crown retention using friction only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>screw retention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>screw retained implant Crown fixation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cement retained implant Crown fixation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conometric concept Acuris system</intervention_name>
    <description>implant crown retention type using friction only</description>
    <arm_group_label>conometric concept (Acuris system)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>screw retention</intervention_name>
    <description>screw retained implant crown</description>
    <arm_group_label>screw retention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cementation</intervention_name>
    <description>cement retained implant crown</description>
    <arm_group_label>cementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  capability of giving an informed consent&#xD;
&#xD;
          -  good health as defined by the subjects medical history (no contraindications as&#xD;
             described in the exclusion criteria below)&#xD;
&#xD;
          -  age 18 to 99 years&#xD;
&#xD;
          -  Good periodontal status: BOP &lt; 20%, PI &lt; 30%, no PD &gt; 4mm&#xD;
&#xD;
          -  No heavy smokers (&lt; 10 cigarettes/day)&#xD;
&#xD;
          -  at least 1 missing tooth in the premolar and molar region (with at least a mesial&#xD;
             neighboring tooth/implant showing adequate hard- and soft tissue situation without the&#xD;
             need of crestal hard- or soft tissue augmentation) either in the maxilla or in the&#xD;
             mandible requiring implant therapy for reconstruction, requiring sinus floor&#xD;
             augmentation or not.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Insufficient bone volume for implant placement requiring GBR (guided bone&#xD;
             regeneration) procedure in crestal area.&#xD;
&#xD;
          -  Heavy Smokers (&gt;10 cigarettes/day)&#xD;
&#xD;
          -  Medication with a contraindication for implant therapy (especially antiresorptive&#xD;
             therapy, ongoing or recently completed local radiotherapy, systematic diseases,&#xD;
             ongoing immunosuppressive therapy, functional disorders like Bruxism).&#xD;
&#xD;
          -  Skeletal immaturity.&#xD;
&#xD;
          -  Any active malignancy or ongoing treatment for malignancy.&#xD;
&#xD;
          -  An active infection (e.g. caries, gingivitis, periodontitis) at or in the neighboring&#xD;
             area of the operative site.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  unable or unwilling to return for follow-up visits for a period of at least 16 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norbert Jakse, UnivProfDDr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dental Medicine and Oral Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth Steyer, Dr.</last_name>
    <phone>0043 69911221489</phone>
    <email>elisabeth.amberger@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Norbert Jakse, UnivProfDDr</last_name>
    <phone>0043 316 385</phone>
    <phone_ext>82921</phone_ext>
    <email>norbert.jakse@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Graz, Department of Dental Medicine and Oral Health, Division of Oral Surgery and Orthodontics</name>
      <address>
        <city>Graz</city>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Jakse, MD</last_name>
      <email>norbert.jakse@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>DeCarlo AA, Grenett HE, Harber GJ, Windsor LJ, Bodden MK, Birkedal-Hansen B, Birkedal-Hansen H. Induction of matrix metalloproteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase. J Periodontal Res. 1998 Oct;33(7):408-20.</citation>
    <PMID>9842506</PMID>
  </reference>
  <reference>
    <citation>Jemt T. Regeneration of gingival papillae after single-implant treatment. Int J Periodontics Restorative Dent. 1997 Aug;17(4):326-33.</citation>
    <PMID>9497723</PMID>
  </reference>
  <reference>
    <citation>Kraus RD, Epprecht A, Hämmerle CHF, Sailer I, Thoma DS. Cemented vs screw-retained zirconia-based single implant reconstructions: A 3-year prospective randomized controlled clinical trial. Clin Implant Dent Relat Res. 2019 Aug;21(4):578-585. doi: 10.1111/cid.12735. Epub 2019 Mar 12.</citation>
    <PMID>30861635</PMID>
  </reference>
  <reference>
    <citation>Lekholm U, Adell R, Lindhe J, Brånemark PI, Eriksson B, Rockler B, Lindvall AM, Yoneyama T. Marginal tissue reactions at osseointegrated titanium fixtures. (II) A cross-sectional retrospective study. Int J Oral Maxillofac Surg. 1986 Feb;15(1):53-61.</citation>
    <PMID>3083006</PMID>
  </reference>
  <reference>
    <citation>Lemos CA, de Souza Batista VE, Almeida DA, Santiago Júnior JF, Verri FR, Pellizzer EP. Evaluation of cement-retained versus screw-retained implant-supported restorations for marginal bone loss: A systematic review and meta-analysis. J Prosthet Dent. 2016 Apr;115(4):419-27. doi: 10.1016/j.prosdent.2015.08.026. Epub 2015 Nov 14. Review.</citation>
    <PMID>26589441</PMID>
  </reference>
  <reference>
    <citation>Lorenzoni M, Pertl C, Wegscheider W, Keil C, Penkner K, Polansky R, Bratschko RO. Retrospective analysis of Frialit-2 implants in the augmented sinus. Int J Periodontics Restorative Dent. 2000 Jun;20(3):255-67.</citation>
    <PMID>11203567</PMID>
  </reference>
  <reference>
    <citation>Ma J, Kitti U, Teronen O, Sorsa T, Husa V, Laine P, Rönkä H, Salo T, Lindqvist C, Konttinen YT. Collagenases in different categories of peri-implant vertical bone loss. J Dent Res. 2000 Nov;79(11):1870-3.</citation>
    <PMID>11145357</PMID>
  </reference>
  <reference>
    <citation>Meissen R, Mintcheva M, Netuschil L. Matrix metalloproteinase-8 levels in peri-implant sulcus fluid adjacent to titanium and zirconium nitride surfaces. Int J Periodontics Restorative Dent. 2014 Jan-Feb;34(1):91-5. doi: 10.11607/prd.1504.</citation>
    <PMID>24396843</PMID>
  </reference>
  <reference>
    <citation>Penarrocha-Oltra D, Monreal-Bello A, Penarrocha-Diago M, Alonso-Perez-Barquero J, Botticelli D, Canullo L. Microbial Colonization of the Peri-Implant Sulcus and Implant Connection of Implants Restored With Cemented Versus Screw-Retained Superstructures: A Cross-Sectional Study. J Periodontol. 2016 Sep;87(9):1002-11. doi: 10.1902/jop.2016.160017. Epub 2016 May 6.</citation>
    <PMID>27153291</PMID>
  </reference>
  <reference>
    <citation>Sailer I, Mühlemann S, Zwahlen M, Hämmerle CH, Schneider D. Cemented and screw-retained implant reconstructions: a systematic review of the survival and complication rates. Clin Oral Implants Res. 2012 Oct;23 Suppl 6:163-201. doi: 10.1111/j.1600-0501.2012.02538.x. Review.</citation>
    <PMID>23062142</PMID>
  </reference>
  <reference>
    <citation>Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306-21. Review.</citation>
    <PMID>16938801</PMID>
  </reference>
  <reference>
    <citation>Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. 2010 Jan;16(1):39-45. doi: 10.1111/j.1601-0825.2009.01603.x. Epub 2009 Jul 8.</citation>
    <PMID>19627514</PMID>
  </reference>
  <reference>
    <citation>Teughels W, Van Assche N, Sliepen I, Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res. 2006 Oct;17 Suppl 2:68-81.</citation>
    <PMID>16968383</PMID>
  </reference>
  <reference>
    <citation>Thoma DS, Sailer I, Mühlemann S, Gil A, Jung RE, Hämmerle CHF. Randomized controlled clinical study of veneered zirconia abutments for single implant crowns: Clinical, histological, and microbiological outcomes. Clin Implant Dent Relat Res. 2018 Dec;20(6):988-996. doi: 10.1111/cid.12674. Epub 2018 Oct 17.</citation>
    <PMID>30328283</PMID>
  </reference>
  <reference>
    <citation>Vindasiute E, Puisys A, Maslova N, Linkeviciene L, Peciuliene V, Linkevicius T. Clinical Factors Influencing Removal of the Cement Excess in Implant-Supported Restorations. Clin Implant Dent Relat Res. 2015 Aug;17(4):771-8. doi: 10.1111/cid.12170. Epub 2013 Nov 14.</citation>
    <PMID>24224895</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MMP-8</keyword>
  <keyword>marginal bone level</keyword>
  <keyword>conometric concept - Acuris</keyword>
  <keyword>crown retention</keyword>
  <keyword>all-ceramic crown</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

